tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 127 are a HOLD (41.37%), 157 are a BUY (51.14%), 23 are a SELL (7.49%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 70.13% that have a potential upside of 33.54% achieved within 298 days.
David Risinger’s has documented 588 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ORKA, Oruka Therapeutics at 16-Mar-2026.
Analyst best performing recommendations are on TECX (TECTONIC THERAPEUTIC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 7/31/2020. The price target of $70 was fulfilled within 5 days with a profit of $8.81 (14.4%) receiving and performance score of 28.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2026
$260
$50.6 (24.16%)
$220
1 months 6 days ago
(25-Feb-2026)
5/6 (83.33%)
$33.08 (14.58%)
168
Buy Since 12-Sep-2025
$299
$89.6 (42.79%)
$284
1 months 13 days ago
(18-Feb-2026)
2/4 (50%)
$70.28 (30.73%)
35
Hold Since 07-Jan-2026
$230
$20.6 (9.84%)
$240
1 months 26 days ago
(05-Feb-2026)
1/2 (50%)
$10.98 (5.01%)
8
Buy Since 24-Jan-2022
$270
$60.6 (28.94%)
$269
1 months 26 days ago
(05-Feb-2026)
17/21 (80.95%)
$50.98 (23.28%)
526
Hold Since 14-May-2025
$230
$20.6 (9.84%)
$235
2 months 4 days ago
(27-Jan-2026)
19/20 (95%)
$6.07 (2.71%)
273
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
